Ukraine will get innovative COVID-19 drugs from U.S. for $20M - Ministry of Health

Ukraine will get innovative COVID-19 drugs from U.S. for $20M - Ministry of Health

Ukrinform
Ukraine will receive innovative drugs against COVID-19 in cooperation with the U.S. government, the Ministry of Health of Ukraine has reported.

Humanitarian aid equivalent to almost $20 million will arrive in Ukraine in the near future and will be delivered to the regions by charitable foundations. Such agreements were finalized as part of Ukrainian President Volodymyr Zelensky's visit to the United States, the report said.

"The U.S. government, together with the manufacturer, will provide us with innovative drugs against COVID-19 as humanitarian aid. They have already been registered by the FDA and are recommended for patients with mild to moderate [COVID-19], especially if there is a risk of transition to severe form," said Health Minister Viktor Liashko.

Some 20,000 vials of Bamlanivimab and 40,000 vials of Etesevimab will be sent to Ukraine. The drugs have already been formed into cargo and are being transported to the airport for shipment to Ukraine.

The Ministry of Health of Ukraine has also purchased 2,784 vials of Tocilizumab and is completing the purchase of 14,346 packs of Remdesivir.

The World Health Organization in August announced a new phase of trials of three potential drugs for the treatment of hospitalized patients with coronavirus.

op


Let’s get started read our news at facebook messenger > > > Click here for subscribe

While citing and using any materials on the Internet, links to the website ukrinform.net not lower than the first paragraph are mandatory. In addition, citing the translated materials of foreign media outlets is possible only if there is a link to the website ukrinform.net and to the website of a foreign media outlet. Citing and using materials in offline media, mobile apps, Smart TV are allowed only with written permission from Ukrinform. News and publications marked as "Advertisement" and "PR" and articles in the section "Releases" include promoted content, and an advertiser is responsible for the content.

© 2015-2021 Ukrinform. All rights reserved.

Website design Studio Laconica

Extended searchHide extended search
By period:
-